03:58 AM EST, 01/27/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Sunday that the US Food and Drug Administration has approved the supplemental biologics license application for once-every-four-weeks lecanemab-irmb intravenous maintenance dosing for treating early Alzheimer's disease. The indication for the drug, also known as Leqembi, is for patients with either mild cognitive impairment or mild dementia after 18...

(Reuters) - Indebted property developer China Vanke said on Monday its chairman Yu Liang and chief executive Zhu Jiusheng applied to resign from their positions, amid intensifying worries over the company's liquidity as it faces several looming debt maturity deadlines this month. (Reporting by Himanshi Akhand in Bengaluru) ...

03:30 AM EST, 01/27/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on January 23, 2025, sold 7,948 shares in Atlassian ( TEAM ) for $2,108,846. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 365,608 shares of the company, with 365,608 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025000512/xslF345X05/primarydocument.xml ...

03:40 AM EST, 01/27/2025 (MT Newswires) -- Inogen (INGN) said Sunday it has entered into a partnership with Jiangsu Yuyue Medical Equipment & Supply with the intention of boosting its portfolio of respiratory products, expanding its research pipeline and accelerating its entry into China. Under the agreement, a Jiangsu Yuyue affiliate will also invest about $27.2 million in Inogen, representing...